News

U2XLab at KIC 2026: Event Recap

2026.10.21 Views 55


Hello from U2XLab! 😊


From October 13 to 15, U2XLab participated as an exhibitor at the

2026 KoNECT-MOHW-MFDS International Conference (KIC 2026), held at Lotte Hotel Seoul, Korea.

During the event, we connected with professionals from

the pharmaceutical, biotechnology, and clinical research industries in Korea and abroad,

exploring opportunities for future business collaboration.


Now in its 12th year, KIC brings together

pharmaceutical and biotechnology companies, contract research organizations (CROs),

healthcare institutions, research organizations, and government representatives from around the world.

The conference provides a platform to share the latest developments in drug development and clinical research,

foster industry dialogue, and identify opportunities for collaboration.

Its exhibition, business partnering meetings, and other programs offer valuable opportunities for

professionals across the industry to connect and exchange insights.



🎤 A New Chapter: Introducing U2XLab to the Industry

This year's KIC held particular significance for U2XLab. Following our transition from SML Meditree to U2XLab, the conference provided an important opportunity to introduce our new name and brand to the wider industry.

At our booth, we introduced U2XLab to visitors from Korea and overseas and presented our core business areas and services, including clinical trial biospecimen analysis. The event enabled us to strengthen relationships with existing contacts while building new connections under the U2XLab name.



🌍 Connecting with Global Partners and Exploring New Opportunities

Throughout the conference, our booth welcomed companies and industry professionals from a wide range of backgrounds. We held meetings with domestic and international organizations, with a particular focus on engaging directly with overseas companies to exchange insights into our respective businesses and areas of interest, and to explore potential avenues for collaboration.

These conversations went beyond introducing our services. They provided an opportunity to better understand one another's expertise and strategic priorities, identify areas of mutual interest, and explore how we could work together to create new business opportunities.

Building on the connections and discussions established at KIC 2026, U2XLab will continue engaging with partners in Korea and abroad, with the aim of translating promising discussions into meaningful business collaborations.



💝A Special Highlight: Our Microbiome Testing Giveaway

To make the exhibition experience more engaging and create opportunities for closer interaction with visitors, U2XLab hosted a giveaway featuring our gut microbiome testing service.

The event attracted interest and participation from visitors, offering a fun and interactive way to learn more about our testing services.

Winners will be notified individually at a later date. We sincerely thank everyone who participated and hope the giveaway provided an enjoyable introduction to U2XLab's services.

We also prepared special gifts for our booth visitors, adding a personal touch to the experience. We are grateful for the warm response and support we received, and we look forward to connecting with more of you at future events. 🧡



🔬 Advancing Clinical Research Through Trusted Biospecimen Analysis

KIC 2026 marked an important milestone for U2XLab—not only as an opportunity to introduce our new brand, but also as a chance to strengthen industry connections and explore new possibilities for collaboration in Korea and around the world.

Drawing on our expertise and experience in clinical trial biospecimen analysis, U2XLab remains committed to meeting the diverse research needs of our clients and delivering reliable, high-quality analytical services.

We would like to extend our sincere thanks to everyone who visited our booth and expressed interest in U2XLab. We look forward to building on these connections and continuing to support our partners through trusted services and new opportunities for collaboration.

Thank you for being part of our journey. We look forward to connecting with you again soon!



Interested in U2XLab's Services and Partnership Opportunities?

Discover U2XLab's service offerings and areas of expertise, from clinical trial biospecimen analysis to a range of research support services, on our official website.

📩 Business Inquiries: bd@u2xlab.com



U2XLab, Your Analytical Partner for R&D Success

Contact Us